US2020323824A1PendingUtilityA1

Novel solid forms of bendamustine hydrochloride

74
Assignee: CEPHALON INCPriority: Mar 26, 2008Filed: Nov 18, 2019Published: Oct 15, 2020
Est. expiryMar 26, 2028(~1.7 yrs left)· nominal 20-yr term from priority
Inventors:Martin Ian CooperLaurent CourvoisierMark EddlestonRobert E. Mckean
C07D 235/16A61K 9/14A61K 9/0019A61P 35/02A61K 47/26A61K 31/4184A61P 35/00A61K 9/19
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A pharmaceutical composition comprising a crystalline form of bendamustine hydrochloride that is Form 4 and produces an X-ray powder diffraction pattern having peaks at 7.8. 10.3, 10.8, 15.5, 19.6, and 26.6±0.2 degrees 2θ.

Join the waitlist — get patent alerts

Track US2020323824A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.